Scott Giberson - Jul 6, 2022 Form 3 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
Director
Signature
/s/ Ilan Katz, attorney-in-fact
Stock symbol
SABS
Transactions as of
Jul 6, 2022
Transactions value $
$0
Form type
3
Date filed
7/13/2022, 05:56 PM
Next filing
Sep 15, 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.